Authors:
Kientz, D
Laforet, M
Isola, H
Cazenave, JP
Citation: D. Kientz et al., Leukodepletion of platelet concentrates and plasma collected with Haemoneties (R) MCS+ apheresis system. Experience of EFS-Alsace, TRANSF AP S, 25(1), 2001, pp. 55-59
Authors:
Leray, C
Wiesel, ML
Freund, M
Cazenave, JP
Gachet, C
Citation: C. Leray et al., Long-chain n-3 fatty acids specifically affect rat coagulation factors dependent on vitamin K - Relation to peroxidative stress, ART THROM V, 21(3), 2001, pp. 459-465
Authors:
Perrault, C
Moog, S
Rubinstein, E
Santer, M
Baas, MJ
de la Salle, C
Ravanat, C
Dambach, J
Freund, M
Santoso, S
Cazenave, JP
Lanza, F
Citation: C. Perrault et al., A novel monoclonal antibody against the extracellular domain of GPIb beta modulates vWF mediated platelet adhesion, THROMB HAEM, 86(5), 2001, pp. 1238-1248
Authors:
Blann, AD
Lanza, F
Galajda, P
Gurney, D
Moog, S
Cazenave, JP
Lip, GYH
Citation: Ad. Blann et al., Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis - The influence of aspirin and cigarette smoking, THROMB HAEM, 86(3), 2001, pp. 777-783
Authors:
Eckly, A
Gendrault, JL
Hechler, B
Cazenave, JP
Gachet, C
Citation: A. Eckly et al., Differential involvement of the P2Y(1) and P2Y(T) receptors in the morphological changes of platelet aggregation, THROMB HAEM, 85(4), 2001, pp. 694-701
Authors:
Ulsemer, P
Strassel, C
Baas, MJ
Salamero, J
Chasserot-Golaz, S
Cazenave, JP
De la Salle, C
Lanza, F
Citation: P. Ulsemer et al., Biosynthesis and intracellular post-translational processing of normal andmutant platelet glycoprotein GPIb-IX, BIOCHEM J, 358, 2001, pp. 295-303
Citation: Jp. Cazenave et al., Design of clinical trials to evaluate the efficacy of platelet transfusion: The euroSPRITE trial for components treated with Helinx (TM) technology, SEM HEMATOL, 38(4), 2001, pp. 46-54
Authors:
Salamero, J
Bausinger, H
Mommaas, AM
Lipsker, D
Proamer, F
Cazenave, JP
Goud, B
de la Salle, H
Hanau, D
Citation: J. Salamero et al., CD1a molecules traffic through the early recycling endosomal pathway in human Langerhans cells, J INVES DER, 116(3), 2001, pp. 401-408
Authors:
Nieswandt, B
Schulte, V
Bergmeier, W
Mokhtari-Nejad, R
Rackebrandt, K
Cazenave, JP
Ohlmann, P
Gachet, C
Zirngibl, H
Citation: B. Nieswandt et al., Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice, J EXP MED, 193(4), 2001, pp. 459-469
Authors:
Deplanque, G
Ceraline, J
Mah-Becherel, MCM
Cazenave, JP
Bergerat, JP
Klein-Soyer, C
Citation: G. Deplanque et al., Caffeine and the G2/M block override: A concept resulting from a misleading cell kinetic delay, independent of functional p53, INT J CANC, 94(3), 2001, pp. 363-369
Authors:
Kauffenstein, G
Bergmeier, W
Eckly, A
Ohlmann, P
Leon, C
Cazenave, JP
Nieswandt, B
Gachet, C
Citation: G. Kauffenstein et al., The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin - a phosphoinositide 3-kinase-dependent mechanism, FEBS LETTER, 505(2), 2001, pp. 281-290
Authors:
Baurand, A
Raboisson, P
Freund, M
Leon, C
Cazenave, JP
Bourguignon, JJ
Gachet, C
Citation: A. Baurand et al., Inhibition of platelet function by administration of MRS2179, a P2Y(1) receptor antagonist, EUR J PHARM, 412(3), 2001, pp. 213-221
Authors:
Leon, C
Freund, M
Ravanat, C
Baurand, A
Cazenave, JP
Gachet, C
Citation: C. Leon et al., Key role of the P2Y(1) receptor in tissue factor-Induced thrombin-dependent acute thromboembolism - Studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist, CIRCULATION, 103(5), 2001, pp. 718-723
Authors:
Moog, S
Mangin, P
Lenain, N
Strassel, C
Ravanat, C
Schuhler, S
Freund, M
Santer, M
Kahn, M
Nieswandt, B
Gachet, C
Cazenave, JP
Lanza, F
Citation: S. Moog et al., Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation, BLOOD, 98(4), 2001, pp. 1038-1046
Authors:
Nieswandt, B
Bergmeier, WG
Eckly, A
Schulte, V
Ohlmann, P
Cazenave, JP
Zirngibl, H
Offermanns, S
Gachet, C
Citation: B. Nieswandt et al., Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation, BLOOD, 97(12), 2001, pp. 3829-3835
Authors:
Dormoy, A
Hanau, D
Tongio, MM
Cazenave, JP
Citation: A. Dormoy et al., Development and validation of a genotyping kit for the eight principal human platelet alloantigen systems, TRANSF CL B, 7(1), 2000, pp. 51-62
Authors:
Baurand, A
Eckly, A
Bari, N
Leon, C
Hechler, B
Cazenave, JP
Gachet, C
Citation: A. Baurand et al., Desensitization of the platelet aggregation response to ADP: Differential down-regulation of the P2Y(1) and P2cyc receptors, THROMB HAEM, 84(3), 2000, pp. 484-491
Authors:
Ulsemer, P
Lanza, F
Baas, MJ
Schwartz, A
Ravanat, C
Briquel, ME
Cranmer, S
Jackson, S
Cazenave, JP
de la Salle, C
Citation: P. Ulsemer et al., Role of the leucine-rich domain of platelet GPIb alpha in correct post-translational processing - The Nancy I Bernard-Soulier mutation expressed on CHO cells, THROMB HAEM, 84(1), 2000, pp. 104-111
Authors:
Fayolle, C
Leray, C
Ohlmann, P
Gutbier, G
Cazenave, JP
Gachet, C
Groscolas, R
Citation: C. Fayolle et al., Lipid composition of blood platelets and erythrocytes of southern elephantseal (Mirounga leonina) and antarctic fur seal (Arctocephalus gazella), COMP BIOC B, 126(1), 2000, pp. 39-47
Authors:
Caillard, S
Leray, C
Kunz, K
Gachet, C
Offner, M
Wiesel, ML
Hannedouchte, T
Cazenave, JP
Moulin, B
Citation: S. Caillard et al., Effects of cerivastatin on lipid profiles, lipid peroxidation and plateletand endothelial activation in renal transplant recipients, TRANSPLAN P, 32(8), 2000, pp. 2787-2788
Authors:
Fayolle, C
Leray, C
Ohlmann, P
Gutbier, G
Cazenave, JP
Gachet, C
Groscolas, R
Citation: C. Fayolle et al., Lipid composition of erythrocytes and thrombocytes of a subantarctic seabird, the king penguin, LIPIDS, 35(4), 2000, pp. 453-459